tiprankstipranks
Achieve Life Sciences announces data from Phase 2 ORCA-V1 trial
PremiumThe FlyAchieve Life Sciences announces data from Phase 2 ORCA-V1 trial
2M ago
Achieve Life Sciences Announces Data from Cytisinicline ORCA-V1 Program to be Presented at Society of General Internal Medicine (SGIM) Annual Meeting
PremiumPress Releases
Achieve Life Sciences Announces Data from Cytisinicline ORCA-V1 Program to be Presented at Society of General Internal Medicine (SGIM) Annual Meeting
2M ago
Achieve Life Sciences price target lowered to $11 from $18 at Oppenheimer
PremiumThe Fly
Achieve Life Sciences price target lowered to $11 from $18 at Oppenheimer
2M ago
Achieve Life Sciences Announces Publication of Cytisinicline Vaping Cessation Trial Results in JAMA Internal Medicine
PremiumPress ReleasesAchieve Life Sciences Announces Publication of Cytisinicline Vaping Cessation Trial Results in JAMA Internal Medicine
3M ago
Achieve Life Sciences files to sell 13.09M shares of common stock for holders
PremiumThe Fly
Achieve Life Sciences files to sell 13.09M shares of common stock for holders
3M ago
Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 9, 2024
PremiumPress Releases
Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 9, 2024
3M ago
Options Volatility and Implied Earnings Moves This Week, March 26 – March 28, 2024
PremiumMarket NewsOptions Volatility and Implied Earnings Moves This Week, March 26 – March 28, 2024
4M ago
Achieve Life Sciences announces data from cytisinicline ORCA program
PremiumThe Fly
Achieve Life Sciences announces data from cytisinicline ORCA program
4M ago
ACHV Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
ACHV Upcoming Earnings Report: What to Expect?
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100